Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Chris Lange | Mar 31, 2020 at 10:21 AM EDT

Will Vivus Be the Next Big Name in Telemedicine?

Vivus shares absolutely exploded on Tuesday after the company announced that it was accelerating the launch of telemedicine and remote…

Lee Jackson | Mar 31, 2020 at 7:05 AM EDT

Why Big Pharmaceutical Stocks May Be the Best Place for Worried Investors Now

Some investors are looking for conservative growth ideas, and big pharma may be the ticket. These four top stocks have…

Douglas A. McIntyre | Mar 31, 2020 at 6:28 AM EDT

Who Will Care for People as Thousands of Doctors Close Their Doors?

A physician crisis based on financial issues is about to begin in America and will get worse as the pandemic…

Paul Ausick | Mar 30, 2020 at 1:09 PM EDT

Will Increased COVID-19 Competition Hurt Aytu Biosciences Stock?

There is plenty of competition among companies wanting to sell coronavirus test kits. Aytu Biosciences has placed a bet on…

Chris Lange | Mar 30, 2020 at 12:27 PM EDT

How Much Cash Can Bio-Path Burn?

Bio-Path stock has taken a beating in the past five years. Investors obviously aren’t happy about this, and the way…

Chris Lange | Mar 30, 2020 at 10:54 AM EDT

Big Pharma Advances on COVID-19

24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel…

Douglas A. McIntyre | Mar 27, 2020 at 6:24 AM EDT

American Doctors Will Go Out of Business by the Thousands

An acute shortage of doctors due to financial issues is about to begin in America and will get worse as…

Chris Lange | Mar 26, 2020 at 11:12 AM EDT

Dynavax New Vaccine: Are Investors Sick of Coronavirus Vaccine Stocks Yet?

Dynavax Technologies shares made a handy gain on Thursday after the company announced that it would be entering the coronavirus…

Chris Lange | Mar 25, 2020 at 9:45 AM EDT

Major Biotechs Get Mixed Message on Short Interest

The March 13 short interest data has been compared with the previous report, and short interest moves in these selected…

Jon C. Ogg | Mar 24, 2020 at 1:50 PM EDT

Compugen Projected to Rise Over 100% in Key Analyst Report

SunTrust Robinson Humphrey has issued a new Buy rating Compugen, and the firm's target price represents more than 100% in…

Chris Lange | Mar 24, 2020 at 10:11 AM EDT

How Coronavirus Stocks Are Holding Up

24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal…

Jon C. Ogg | Mar 23, 2020 at 11:18 AM EDT

Is GenMark Diagnostics Underappreciated in the COVID-19 Fight?

GenMark Diagnostics stock has really not made any of the zany exponential gains that have been seen in other coronavirus-related…

Chris Lange | Mar 23, 2020 at 7:05 AM EDT

Aytu BioScience Soars, Pending Approval of Coronavirus Test

Aytu BioScience was largely unknown until it announced that it had a test for COVID-19. Since then, it has seen…

Douglas A. McIntyre | Mar 23, 2020 at 6:18 AM EDT

Where Are the Military’s 130,000 Medical Personnel?

Private and public hospitals need thousands of medical professionals in their frontline fight to care for the surging number of…

Chris Lange | Mar 20, 2020 at 11:34 AM EDT

Will Coronavirus Stocks End the Week With a Bang or a Whimper?

24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal…

1 … 65 66 67 68 69 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Will Vivus Be the Next Big Name in Telemedicine?

Why Big Pharmaceutical Stocks May Be the Best Place for Worried Investors Now

Who Will Care for People as Thousands of Doctors Close Their Doors?

Will Increased COVID-19 Competition Hurt Aytu Biosciences Stock?

How Much Cash Can Bio-Path Burn?

Big Pharma Advances on COVID-19

American Doctors Will Go Out of Business by the Thousands

Dynavax New Vaccine: Are Investors Sick of Coronavirus Vaccine Stocks Yet?

Major Biotechs Get Mixed Message on Short Interest

Compugen Projected to Rise Over 100% in Key Analyst Report

How Coronavirus Stocks Are Holding Up

Is GenMark Diagnostics Underappreciated in the COVID-19 Fight?

Aytu BioScience Soars, Pending Approval of Coronavirus Test

Where Are the Military’s 130,000 Medical Personnel?

Will Coronavirus Stocks End the Week With a Bang or a Whimper?

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

What It Takes to Retire on the Italian Riviera at 60 on $1.1 Million and Keep Your Principal

$400,000 in Employer Stock Inside Your 401(k)? This Tax Rule Could Save You $65,000 Before You Retire

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

What It Takes to Retire on the Italian Riviera at 60 on $1.1 Million and Keep Your Principal

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

What It Takes to Retire on the Italian Riviera at 60 on $1.1 Million and Keep Your Principal

Health and Healthcare Articles

All Health and Healthcare Articles

Will Vivus Be the Next Big Name in Telemedicine?

Why Big Pharmaceutical Stocks May Be the Best Place for Worried Investors Now

Who Will Care for People as Thousands of Doctors Close Their Doors?

Will Increased COVID-19 Competition Hurt Aytu Biosciences Stock?

How Much Cash Can Bio-Path Burn?

Big Pharma Advances on COVID-19

American Doctors Will Go Out of Business by the Thousands

Dynavax New Vaccine: Are Investors Sick of Coronavirus Vaccine Stocks Yet?

Major Biotechs Get Mixed Message on Short Interest

Compugen Projected to Rise Over 100% in Key Analyst Report

How Coronavirus Stocks Are Holding Up

Is GenMark Diagnostics Underappreciated in the COVID-19 Fight?

Aytu BioScience Soars, Pending Approval of Coronavirus Test

Where Are the Military’s 130,000 Medical Personnel?

Will Coronavirus Stocks End the Week With a Bang or a Whimper?

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

What It Takes to Retire on the Italian Riviera at 60 on $1.1 Million and Keep Your Principal

$400,000 in Employer Stock Inside Your 401(k)? This Tax Rule Could Save You $65,000 Before You Retire

Featured Reads

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

What It Takes to Retire on the Italian Riviera at 60 on $1.1 Million and Keep Your Principal